Category: Psychedelic Bulletin - Page 4 - Psychedelic Alpha

Read more about the article Pα+ Psychedelic Bulletin #169: Brin Backs Soneira, But Patent Questions Loom Large; J&J Seeks Spravato Monotherapy Approval; Canadian Study to Parse Out Role of Psychotherapy

Pα+ Psychedelic Bulletin #169: Brin Backs Soneira, But Patent Questions Loom Large; J&J Seeks Spravato Monotherapy Approval; Canadian Study to Parse Out Role of Psychotherapy

Post published:July 26, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #168: California’s Psychedelic Research Bottleneck Ends Today; Neşe Devenot’s Letter to the Editor; Oregon’s Psilocybin Services a Year In; Disability and Psychedelics

Pα+ Psychedelic Bulletin #168: California’s Psychedelic Research Bottleneck Ends Today; Neşe Devenot’s Letter to the Editor; Oregon’s Psilocybin Services a Year In; Disability and Psychedelics

Post published:July 19, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #167: Lykos Insiders, Affiliates Respond to Critics; FDA-Affiliated Workshop Discusses Ketamine; EMA Associates Publish Recap of Psychedelics Workshop

Pα+ Psychedelic Bulletin #167: Lykos Insiders, Affiliates Respond to Critics; FDA-Affiliated Workshop Discusses Ketamine; EMA Associates Publish Recap of Psychedelics Workshop

Post published:July 12, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #166: Crenshaw and Musk Weigh In on MDMA; Drug Devs Clarify Trial Design In Wake of AdComm; Mini Interview: Joshua Ismin, Psylo

Pα+ Psychedelic Bulletin #166: Crenshaw and Musk Weigh In on MDMA; Drug Devs Clarify Trial Design In Wake of AdComm; Mini Interview: Joshua Ismin, Psylo

Post published:July 5, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #165: A Closer Look at a Buzzy Oral Ketamine for Depression Study; UN Weighs In on Psychedelics; Another CA Psychedelics Bill Fails

Pα+ Psychedelic Bulletin #165: A Closer Look at a Buzzy Oral Ketamine for Depression Study; UN Weighs In on Psychedelics; Another CA Psychedelics Bill Fails

Post published:June 28, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #164: Lykos Dominates News Cycle; EPIsoDE Trial Readout; EU Drug Report Discusses Psychedelics; DEA Should Improve RFRA Petition Process; Other News

Pα+ Psychedelic Bulletin #164: Lykos Dominates News Cycle; EPIsoDE Trial Readout; EU Drug Report Discusses Psychedelics; DEA Should Improve RFRA Petition Process; Other News

Post published:June 14, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #163: Tempering Excitement Around Recent Raises; Compass Shares Cut of Open-Label PTSD Data; Other News

Pα+ Psychedelic Bulletin #163: Tempering Excitement Around Recent Raises; Compass Shares Cut of Open-Label PTSD Data; Other News

Post published:May 17, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #162: EQUULUS Therapeutics Emerges from Stealth; Responses to ICER’s Draft Evidence Report on Lykos’ MDMA; and more…

Pα+ Psychedelic Bulletin #162: EQUULUS Therapeutics Emerges from Stealth; Responses to ICER’s Draft Evidence Report on Lykos’ MDMA; and more…

Post published:April 25, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #161: Numinus Shifts Focus to US; Algernon Makes DMT for Stroke Lead Asset; atai Pivots to IV Ibogaine

Pα+ Psychedelic Bulletin #161: Numinus Shifts Focus to US; Algernon Makes DMT for Stroke Lead Asset; atai Pivots to IV Ibogaine

Post published:April 17, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #160: Mutual Recognition for MDMA-AT in the UK? Beckley Shares Cut of 5-MeO-DMT Data; and more

Pα+ Psychedelic Bulletin #160: Mutual Recognition for MDMA-AT in the UK? Beckley Shares Cut of 5-MeO-DMT Data; and more

Post published:March 29, 2024
Post category:Psychedelic Bulletin Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.